MediWound Ltd. (MDWD)
NASDAQ: MDWD · IEX Real-Time Price · USD
18.60
-2.29 (-10.96%)
At close: Jul 19, 2024, 4:00 PM
18.70
+0.10 (0.54%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

MediWound Statistics

Total Valuation

MediWound has a market cap or net worth of $172.67 million. The enterprise value is $143.57 million.

Market Cap 172.67M
Enterprise Value 143.57M

Important Dates

The next estimated earnings date is Tuesday, August 13, 2024, before market open.

Earnings Date Aug 13, 2024
Ex-Dividend Date n/a

Share Statistics

MediWound has 9.28 million shares outstanding.

Shares Outstanding 9.28M
Owned by Insiders (%) 26.30%
Owned by Institutions (%) 32.00%
Float 5.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.70
Forward PS 6.65
PB Ratio 7.44
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.23
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.28.

Current Ratio 1.98
Quick Ratio 1.84
Debt / Equity 0.28
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.38

Financial Efficiency

Return on equity (ROE) is -41.50% and return on invested capital (ROIC) is -50.13%.

Return on Equity (ROE) -41.50%
Return on Assets (ROA) -19.60%
Return on Capital (ROIC) -50.13%
Revenue Per Employee $198,510
Profits Per Employee -$127,520
Employee Count 100
Asset Turnover 0.31
Inventory Turnover 5.64

Taxes

In the past 12 months, MediWound has paid $204,000 in taxes.

Income Tax 204,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +88.83% in the last 52 weeks. The beta is 0.82, so MediWound's price volatility has been lower than the market average.

Beta (5Y) 0.82
52-Week Price Change +88.83%
50-Day Moving Average 17.07
200-Day Moving Average 13.49
Relative Strength Index (RSI) 52.20
Average Volume (20 Days) 403,105

Short Selling Information

Short Interest 266,578
Short Previous Month 259,253
Short % of Shares Out 3.45%
Short % of Float n/a
Short Ratio (days to cover) 2.44

Income Statement

In the last 12 months, MediWound had revenue of $19.85 million and -$12.75 million in losses. Loss per share was -$1.38.

Revenue 19.85M
Gross Profit 3.36M
Operating Income -14.87M
Pretax Income -12.55M
Net Income -12.75M
EBITDA -7.46M
EBIT -8.83M
Loss Per Share -$1.38
Full Income Statement

Balance Sheet

The company has $35.57 million in cash and $6.47 million in debt, giving a net cash position of $29.10 million or $3.13 per share.

Cash & Cash Equivalents 35.57M
Total Debt 6.47M
Net Cash 29.10M
Net Cash Per Share $3.13
Equity (Book Value) 23.20M
Book Value Per Share 2.50
Working Capital 21.86M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.73 million and capital expenditures -$6.22 million, giving a free cash flow of -$21.94 million.

Operating Cash Flow -15.73M
Capital Expenditures -6.22M
Free Cash Flow -21.94M
FCF Per Share -$2.38
Full Cash Flow Statement

Margins

Gross margin is 16.92%, with operating and profit margins of -74.91% and -64.24%.

Gross Margin 16.92%
Operating Margin -74.91%
Pretax Margin -63.21%
Profit Margin -64.24%
EBITDA Margin -37.60%
EBIT Margin -44.49%
FCF Margin -110.54%

Dividends & Yields

MediWound does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.09%
Shareholder Yield -10.09%
Earnings Yield -7.39%
FCF Yield -12.71%

Analyst Forecast

The average price target for MediWound is $32.00, which is 72.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target $32.00
Price Target Difference 72.04%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 46.44%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 20, 2022. It was a reverse split with a ratio of 1:7.

Last Split Date Dec 20, 2022
Split Type Reverse
Split Ratio 1:7

Scores

Altman Z-Score n/a
Piotroski F-Score n/a